Independence Medical Group of Central California, INC.

Independence Medical Group of Central California, INC. was paid $2.52M by Medicaid between Jan 2018 and Sep 2018, across 339 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 27% of everything it billed.

33Billing provider infoINDEPENDENCE MEDICAL GROUP OF CENTRAL CALIFORNIA, INC.
VISALIA, CA 93291

33aNPI1477796464assigned 04/07/2009

33bProvider typeHealth Maintenance Organization

28Total paid$2.52M

24GClaims283,860

24DCodes billed339

24AFirst – last monthJan 2018 – Sep 2018

Compared with peers

Next to other Health Maintenance Organization providers in California

Rank by total paid#30 of 151

Median peer was paid$59K

This provider vs. median43×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	283,860	$2.52M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	27%	68,046	54,717	$678K
S9542	Home injectable therapy, not otherwise classified, including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem	13%	318	300	$323K
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	4.4%	5,903	5,384	$111K
J3490	Unclassified drugs	2.8%	287	276	$71K
59425		2.3%	2,086	1,423	$58K
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	1.9%	2,331	2,280	$48K
81025		1.9%	2,311	2,191	$48K
81002		1.7%	3,588	3,114	$44K
85018		1.7%	6,976	6,815	$43K
99173		1.6%	3,935	3,913	$40K
81003		1.6%	6,177	5,715	$40K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	1.5%	252	248	$38K

327 more codes

99243		1.3%	530	$33K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	1.3%	5,820	$32K
92551		1.3%	3,303	$32K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	1.2%	2,173	$30K
94760		1.1%	2,923	$28K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	1.1%	1,432	$27K
99204	Doctor's office visit, new patient (more involved)	<1%	787	$24K
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	<1%	2,305	$23K
99284	Emergency room visit (serious)	<1%	647	$21K
92552		<1%	1,620	$21K
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	<1%	1,626	$21K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	417	$20K
99285	Emergency room visit (most serious)	<1%	311	$18K
71046	Radiologic examination, chest; 2 views	<1%	1,343	$18K
93015		<1%	158	$17K
3074F		<1%	2,452	$16K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	358	$16K
3078F		<1%	2,171	$15K
36415	Collection of venous blood by venipuncture	<1%	9,550	$15K
99203	Doctor's office visit, new patient (routine)	<1%	574	$14K
99215	Doctor's office visit, returning patient (complex)	<1%	334	$12K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	71	$12K
92081		<1%	946	$12K
93000		<1%	520	$11K
J7050	Infusion, normal saline solution, 250 cc	<1%	156	$11K
97014		<1%	809	$11K
99051		<1%	556	$11K
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	<1%	648	$11K
J0153	Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)	<1%	103	$10K
82947		<1%	1,406	$10K
78492		<1%	58	$9K
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	<1%	277	$9K
H1003	Prenatal care, at-risk enhanced service; education	<1%	569	$9K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	182	$9K
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	1,034	$9K
T4541	Incontinence product, disposable underpad, large, each	<1%	268	$8K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	378	$8K
77063	Screening digital breast tomosynthesis, bilateral	<1%	277	$8K
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	<1%	72	$8K
59514		<1%	15	$7K
86580		<1%	1,133	$7K
D1206	Topical application of fluoride varnish	<1%	441	$7K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	584	$7K
85014		<1%	546	$7K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	41	$7K
90670		<1%	914	$7K
82962		<1%	843	$7K
94200		<1%	740	$7K
81005		<1%	370	$7K
99000		<1%	956	$6K
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	<1%	663	$6K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	113	$6K
3079F		<1%	907	$6K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	148	$6K
S9088	Services provided in an urgent care center (list in addition to code for service)	<1%	271	$6K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	536	$6K
92012	Ophthalmological services: medical examination and evaluation, intermediate, established patient	<1%	70	$6K
59409	Vaginal delivery only (with or without episiotomy and/or forceps)	<1%	12	$6K
95117		<1%	576	$5K
88307		<1%	84	$5K
81000		<1%	859	$5K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	656	$5K
G9637	Final reports with documentation of one or more dose reduction techniques (e.g., automated exposure control, adjustment of the ma and/or kv according to patient size, use of iterative reconstruction technique)	<1%	273	$4K
90460	Immunization administration through 18 years of age via any route, first or only component	<1%	344	$4K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	3,562	$4K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	331	$4K
3044F		<1%	240	$4K
G9318	Imaging study named according to standardized nomenclature	<1%	272	$4K
T4535	Disposable liner/shield/guard/pad/undergarment, for incontinence, each	<1%	141	$4K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	3,560	$4K
A9555	Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries	<1%	62	$4K
96151		<1%	320	$4K
36410		<1%	418	$3K
87510		<1%	196	$3K
88304		<1%	135	$3K
92250		<1%	81	$3K
00170	Anesthesia for intraoral procedures, including biopsy	<1%	102	$3K
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	154	$3K
90633		<1%	475	$3K
74177	Computed tomography, abdomen and pelvis; with contrast material	<1%	115	$3K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	12	$3K
76830	Ultrasound, transvaginal	<1%	76	$3K
90700		<1%	251	$3K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	806	$3K
73562		<1%	200	$3K
96110	Developmental screening, with scoring and documentation, per standardized instrument	<1%	292	$3K
99401		<1%	173	$3K
96127		<1%	234	$3K
87480		<1%	200	$3K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	1,067	$3K
3075F		<1%	375	$3K
93010	Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only	<1%	150	$2K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	419	$2K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	103	$2K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	476	$2K
90686		<1%	584	$2K
87797		<1%	168	$2K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	138	$2K
71045	Radiologic examination, chest; single view	<1%	374	$2K
70450	Computed tomography, head or brain; without contrast material	<1%	155	$2K
88312		<1%	80	$2K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	251	$2K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	25	$2K
76642		<1%	58	$2K
87430		<1%	130	$2K
90648		<1%	415	$2K
90680		<1%	251	$2K
J1050	Injection, medroxyprogesterone acetate, 1 mg	<1%	70	$2K
98940		<1%	264	$2K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	12,633	$2K
90651		<1%	160	$2K
88342		<1%	28	$2K
3077F		<1%	335	$2K
S0020	Injection, bupivicaine hydrochloride, 30 ml	<1%	35	$2K
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	49	$2K
97139		<1%	322	$2K
90461		<1%	176	$2K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	48	$2K
93880		<1%	12	$2K
T4522	Adult sized disposable incontinence product, brief/diaper, medium, each	<1%	41	$2K
90716		<1%	237	$1K
72100		<1%	72	$1K
97010		<1%	403	$1K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	839	$1K
90715		<1%	92	$1K
90713		<1%	106	$1K
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	<1%	13	$1K
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	<1%	150	$1K
80053	Comprehensive metabolic panel	<1%	10,304	$1K
A4267	Contraceptive supply, condom, male, each	<1%	40	$1K
Q0091	Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory	<1%	145	$1K
90707		<1%	250	$1K
92134		<1%	13	$1K
90723		<1%	198	$1K
94010		<1%	61	$1K
99242		<1%	12	$1K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	218	$967.55
95115		<1%	185	$843.73
73030		<1%	55	$792.14
G0467	Community health center visit, returning patient	<1%	403	$732.79
81220	CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants	<1%	17	$720.00
81001		<1%	1,973	$707.40
90734		<1%	77	$707.02
T1015	A visit at a community health center or clinic (one all-in rate)	<1%	13	$661.49
3080F		<1%	101	$624.88
90688		<1%	184	$617.23
90647		<1%	140	$602.74
99396	Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years	<1%	45	$594.16
87086	Culture, bacterial; quantitative colony count, urine	<1%	2,205	$570.26
90620		<1%	32	$486.08
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	33	$473.51
83735		<1%	611	$460.36
90656		<1%	23	$457.36
90472	Immunization administration, each additional vaccine (list separately)	<1%	74	$447.38
76641		<1%	15	$437.64
73630		<1%	38	$429.15
72110		<1%	17	$426.84
97035		<1%	120	$420.00
11721		<1%	15	$405.55
A6250	Skin sealants, protectants, moisturizers, ointments, any type, any size	<1%	55	$385.98
A4927	Gloves, non-sterile, per 100	<1%	27	$385.87
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	36	$385.00
99238	Hospital discharge day management, 30 minutes or less	<1%	13	$379.16
72081		<1%	12	$375.50
84484		<1%	354	$374.82
80048	Basic metabolic panel (calcium, ionized)	<1%	808	$371.39
90696		<1%	14	$359.01
83690		<1%	744	$344.31
80061	Lipid panel	<1%	7,311	$331.40
J1030	Injection, methylprednisolone acetate, 40 mg	<1%	41	$329.26
90658		<1%	53	$322.25
88142		<1%	170	$321.80
97161		<1%	46	$315.00
83036	Hemoglobin; glycosylated (A1C)	<1%	7,464	$307.43
85730		<1%	525	$300.30
A9150	Non-prescription drugs	<1%	30	$280.00
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	14	$279.32
G0101	Cervical or vaginal cancer screening; pelvic and clinical breast examination	<1%	16	$273.20
20550		<1%	12	$255.00
85610		<1%	810	$253.66
97164		<1%	14	$250.00
99223	Prolong inpt eval add15 m	<1%	16	$240.30
87081		<1%	511	$232.09
90685		<1%	85	$230.19
99174		<1%	127	$219.30
36400		<1%	117	$219.06
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	611	$217.64
73130		<1%	14	$215.71
84703		<1%	495	$209.51
87040		<1%	128	$191.57
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	4,200	$177.37
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	523	$173.47
97803		<1%	19	$159.79
87070		<1%	442	$158.76
90756		<1%	14	$157.00
87660		<1%	30	$148.63
86901		<1%	629	$139.17
88141		<1%	123	$136.12
83655		<1%	1,067	$134.21
36416		<1%	12	$128.48
Q3014	Telehealth originating site facility fee	<1%	13	$128.08
84702		<1%	539	$126.10
90674		<1%	37	$124.62
83605		<1%	93	$121.99
90649		<1%	16	$114.39
92227		<1%	13	$112.66
87186		<1%	796	$105.58
3015F		<1%	13	$100.03
80069		<1%	260	$99.72
83051		<1%	26	$97.24
T1014	Telehealth transmission, per minute, professional services bill separately	<1%	13	$95.96
80076		<1%	579	$89.80
S0302	Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service)	<1%	13	$89.66
83970		<1%	142	$78.95
83880		<1%	163	$75.53
G8510	Screening for depression is documented as negative, a follow-up plan is not required	<1%	12	$72.00
86900		<1%	615	$71.92
84100		<1%	377	$69.57
83550		<1%	772	$60.99
86850		<1%	617	$54.95
82550		<1%	88	$53.06
87077		<1%	199	$46.97
84443	Thyroid stimulating hormone (TSH)	<1%	7,438	$34.33
82150		<1%	198	$32.28
86592		<1%	1,665	$30.21
87340		<1%	590	$25.91
86141		<1%	102	$23.39
83615		<1%	121	$23.20
86140		<1%	740	$20.07
80306		<1%	49	$19.48
80074		<1%	608	$15.35
84550		<1%	773	$14.17
84436		<1%	1,322	$12.57
82607		<1%	1,030	$11.67
87088		<1%	200	$9.90
82247		<1%	57	$9.11
82310		<1%	52	$7.93
83540		<1%	840	$7.54
82728		<1%	497	$7.52
84520		<1%	83	$7.46
82565		<1%	253	$3.81
84153		<1%	498	$3.29
87205		<1%	12	$2.19
87046		<1%	151	$2.18
85027		<1%	604	$1.14
84132		<1%	43	$0.69
82105		0%	50	$0.00
85652		0%	966	$0.00
82043		0%	1,143	$0.00
83001		0%	225	$0.00
88738		0%	18	$0.00
82378		0%	24	$0.00
86803		0%	260	$0.00
86171		0%	177	$0.00
83002		0%	207	$0.00
82746		0%	877	$0.00
86706		0%	123	$0.00
84479		0%	855	$0.00
82670		0%	97	$0.00
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	0%	1,521	$0.00
86695		0%	123	$0.00
80047		0%	33	$0.00
86376		0%	137	$0.00
84480		0%	394	$0.00
82950		0%	393	$0.00
84144		0%	45	$0.00
87522	Neg quan hep c or qual rna	0%	13	$0.00
82951		0%	33	$0.00
99383		0%	34	$0.00
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	0%	136	$0.00
82784		0%	33	$0.00
86762		0%	447	$0.00
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	0%	194	$0.00
86780		0%	37	$0.00
82952		0%	31	$0.00
86160		0%	31	$0.00
86635		0%	93	$0.00
99024		0%	42	$0.00
83021		0%	31	$0.00
86255		0%	13	$0.00
86225		0%	42	$0.00
82465		0%	205	$0.00
84481		0%	235	$0.00
A4259	Lancets, per box of 100	0%	32	$0.00
82274		0%	574	$0.00
86709		0%	26	$0.00
84439		0%	1,931	$0.00
86003		0%	432	$0.00
86431		0%	408	$0.00
82785		0%	273	$0.00
87150		0%	141	$0.00
87338		0%	192	$0.00
85060		0%	15	$0.00
82570		0%	862	$0.00
87177		0%	86	$0.00
84156		0%	186	$0.00
84146		0%	196	$0.00
87427		0%	148	$0.00
85045		0%	299	$0.00
82140		0%	52	$0.00
86677		0%	64	$0.00
87209		0%	85	$0.00
86038		0%	458	$0.00
84403		0%	247	$0.00
83516		0%	103	$0.00
82248		0%	14	$0.00
83013		0%	90	$0.00
84460		0%	269	$0.00
84450		0%	249	$0.00
83721		0%	30	$0.00
90710		0%	14	$0.00
87481		0%	271	$0.00
82977		0%	106	$0.00
86200		0%	161	$0.00
86696		0%	131	$0.00
86480		0%	30	$0.00
86331		0%	168	$0.00
87045		0%	152	$0.00
87400		0%	17	$0.00
90473		0%	13	$0.00
83525		0%	29	$0.00
82652		0%	15	$0.00
86235		0%	63	$0.00
87420		0%	17	$0.00
87075		0%	13	$0.00
80164		0%	13	$0.00
83718		0%	15	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialHABERKERN, CHARLES (VICE PRESIDENT)